Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Advances in the treatment of neurofibromatosis-associated tumours.

Lin AL, Gutmann DH.

Nat Rev Clin Oncol. 2013 Nov;10(11):616-24. doi: 10.1038/nrclinonc.2013.144. Epub 2013 Aug 13. Review.

PMID:
23939548
2.

Neurofibromatosis-related tumors: emerging biology and therapies.

Karajannis MA, Ferner RE.

Curr Opin Pediatr. 2015 Feb;27(1):26-33. doi: 10.1097/MOP.0000000000000169. Review.

3.

Mouse models of neurofibromatosis 1 and 2.

Gutmann DH, Giovannini M.

Neoplasia. 2002 Jul-Aug;4(4):279-90.

4.

Neurofibroma and schwannoma.

Ferner RE, O'Doherty MJ.

Curr Opin Neurol. 2002 Dec;15(6):679-84. Review.

PMID:
12447105
5.

Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting.

Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Evans DG, Giancotti F, Hanemann CO, Ingram D, Lloyd AC, Mayes DA, Messiaen L, Morrison H, North K, Packer R, Pan D, Stemmer-Rachamimov A, Upadhyaya M, Viskochil D, Wallace MR, Hunter-Schaedle K, Ratner N.

Acta Neuropathol. 2012 Mar;123(3):369-80. doi: 10.1007/s00401-011-0905-0. Epub 2011 Nov 16.

6.

CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H.

Am J Med Genet A. 2014 Mar;164A(3):563-78. doi: 10.1002/ajmg.a.36312. Epub 2014 Jan 17.

7.

Neurofibromatosis types 1 and 2.

Yohay K.

Neurologist. 2006 Mar;12(2):86-93. Review.

PMID:
16534445
8.

Neurofibromatosis and associated tumour suppressor genes.

Zwarthoff EC.

Pathol Res Pract. 1996 Jul;192(7):647-57. Review.

PMID:
8880865
9.

Neurofibromatosis.

Gerber PA, Antal AS, Neumann NJ, Homey B, Matuschek C, Peiper M, Budach W, Bölke E.

Eur J Med Res. 2009 Mar 17;14(3):102-5. Review.

10.

Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.

Lasota J, Wasag B, Dansonka-Mieszkowska A, Karcz D, Millward CL, Ryś J, Stachura J, Sobin LH, Miettinen M.

Lab Invest. 2003 Sep;83(9):1361-71.

PMID:
13679444
11.

Neurofibromatosis 2.

Baser ME, R Evans DG, Gutmann DH.

Curr Opin Neurol. 2003 Feb;16(1):27-33. Review.

PMID:
12544854
12.

The neurofibromatosis type 2 gene is inactivated in schwannomas.

Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA.

Hum Mol Genet. 1994 Jan;3(1):147-51.

PMID:
8162016
13.

Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.

Kimura Y, Saya H, Nakao M.

Neuropathology. 2000 Sep;20(3):153-60. Review.

PMID:
11132929
14.

Neurofibromatosis: part 2--clinical management.

Batista PB, Bertollo EM, Costa Dde S, Eliam L, Cunha KS, Cunha-Melo JR, Darrigo Junior LG, Geller M, Gianordoli-Nascimento IF, Madeira LG, Mendes HM, Miranda DM, Mata-Machado NA, Morato EG, Pavarino ÉC, Pereira LB, Rezende NA, Rodrigues Lde O, Sette JB.

Arq Neuropsiquiatr. 2015 Jun;73(6):531-43. doi: 10.1590/0004-282X20150042.

15.

Neurofibromatosis.

McClatchey AI.

Annu Rev Pathol. 2007;2:191-216. Review.

PMID:
18039098
16.

Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.

Gottfried ON, Viskochil DH, Couldwell WT.

Neurosurg Focus. 2010 Jan;28(1):E8. doi: 10.3171/2009.11.FOCUS09221.

PMID:
20043723
17.

Progress toward the isolation and characterization of the genes causing neurofibromatosis.

Menon AG, Gusella JF, Seizinger BR.

Brain Pathol. 1990 Sep;1(1):33-40. Review.

PMID:
1669691
18.

Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP, Lonser RR, Asthagiri AR.

J Neurosurg. 2012 Jul;117(1):109-17. doi: 10.3171/2012.3.JNS111649. Epub 2012 Apr 13.

19.
20.

Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Laycock-van Spyk S, Thomas N, Cooper DN, Upadhyaya M.

Hum Genomics. 2011 Oct;5(6):623-90. Review.

Supplemental Content

Support Center